
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current BMK market cap is 207.29M. The company's latest EPS is GBP -0.0533 and P/E is -5.25.
Year End 30 September 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
Total Revenue | 120.39M | 125.06M | 158.28M | 169.74M | 147.73M |
Operating Income | -19.82M | -5.33M | -1.04M | -10.79M | -27.06M |
Net Income | -32.92M | -12.89M | -32.09M | -23.15M | -39.46M |
Year End 30 September 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
Total Assets | 489.04M | 481.99M | 526.57M | 471.3M | 384.9M |
Total Liabilities | 193.6M | 202.39M | 203.29M | 188.68M | 160.63M |
Total Equity | 295.44M | 279.6M | 323.29M | 282.62M | 224.27M |
Year End 30 September 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
Operating | -4.06M | 5.79M | 10.81M | 20.01M | 2M |
Investing | 30.38M | -23.09M | -11.22M | -5.27M | -2.83M |
Financing | 30.13M | -14.67M | -6.92M | -12.33M | -10.97M |
Market Cap | 207.29M |
Price to Earnings Ratio | -5.25 |
Price to Sales Ratio | 1.4 |
Price to Cash Ratio | 8.97 |
Price to Book Ratio | 0.92 |
Dividend Yield | - |
Shares Outstanding | 740.34M |
Average Volume (1 week) | 89.28k |
Average Volume (1 Month) | 79.13k |
52 Week Change | -39.00% |
52 Week High | 48.00 |
52 Week Low | 26.00 |
Spread (Intraday) | 1.4 (4.93%) |
Company Name | Benchmark Holdings Plc |
Address |
benchmark house sheffield S35 1QN |
Website | https://benchmarkplc.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions